Over SEK 34 million from the Swedish Cancer Society to MedH researchers

Marcus Buggert, CIM
Granted: SEK 3 000 000, over two years. 
Project title: Pinpoint mechanisms of T cell dysfunction in chronic lymphocytic leukemia to generate superior CAR T cells.

Maria Eriksson, ICCA
Granted: SEK 3 000 000, over two years.
Project title: Towards a Genetic Atlas of Somatic Mutagenesis in Healthy Human Cells - Focus on Somatic Mutations in the Oral Epithelia in Snus Users.

Hannes Hagström, GUT
Granted: SEK 4 500 000, over two years. 
Project title: Prediction and prevention of liver cancer.

Eva Hellström Lindberg, HERM
Granted: SEK 7 500 000, over two years.
Project title: Disease mechanisms and molecularly targeted treatment in myelodysplastic syndromes.

Nicole Marquardt, HERM
Granted: SEK 3 000 000 SEK, over two years. 
Project title: Dissecting lung NK cell adaptation and function in the healthy tissue and tumor microenvironment .

Jenny Mjösberg, CIM
Granted: SEK 4 500 000 SEK, over two years. 
Project title: Harnessing the potential of intratumoral lymphocytes to improve outcomes for patients with advanced and metastatic colorectal cancer (CRC) with and without neoadjuvant chemotherapy.

Andrea Ponzetta, CIM
Granted: SEK 1 600 000 SEK, over one year. 
Project title: Leveraging peritoneal immunity to predict and improve treatment outcomes in metastatic gastric cancer.

Michael Uhlin, HERM
Granted: SEK 3 000 000 SEK, over two years.
Project title: γδ T cells in cancer and Immune therapy.

Tim Willinger, CIM
Granted: SEK 2 000 000, over one year. 
Project title: Immune sensing of cholesterol metabolites in anti-cancer immunity.

Petter Woll, HERM
Granted: SEK 1 600 000 SEK, over one year. 
Project title: Mechanisms for TP53-mutant immune surveillance and escape in myeloid malignancies treated with hypomethylation agents.

Magnus Tobiasson, HERM
Granted: SEK 600 000, over two years.
Project title: Nordiska MDS gruppen.